These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22936807)

  • 1. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.
    Wang RX; Yu CR; Mahdi RM; Egwuagu CE
    J Biol Chem; 2012 Oct; 287(43):36012-21. PubMed ID: 22936807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.
    Escobar T; Yu CR; Muljo SA; Egwuagu CE
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4017-25. PubMed ID: 23674757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
    Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
    Bing SJ; Shemesh I; Chong WP; Horai R; Jittayasothorn Y; Silver PB; Sredni B; Caspi RR
    J Autoimmun; 2019 Jun; 100():52-61. PubMed ID: 30853312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
    Chong WP; Horai R; Mattapallil MJ; Silver PB; Chen J; Zhou R; Sergeev Y; Villasmil R; Chan CC; Caspi RR
    J Autoimmun; 2014 May; 50():12-22. PubMed ID: 24021664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice.
    Mbanefo EC; Yan M; Kang M; Alhakeem SA; Jittayasothorn Y; Yu CR; Parihar A; Singh S; Egwuagu CE
    Front Immunol; 2021; 12():724609. PubMed ID: 34603297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases.
    Liu X; Lee YS; Yu CR; Egwuagu CE
    J Immunol; 2008 May; 180(9):6070-6. PubMed ID: 18424728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU).
    Sun D; Liang D; Kaplan HJ; Shao H
    Cytokine; 2015 Jul; 74(1):76-80. PubMed ID: 25742774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
    Oladipupo FO; Yu CR; Olumuyide E; Jittaysothorn Y; Choi JK; Egwuagu CE
    Sci Rep; 2020 Oct; 10(1):16188. PubMed ID: 33004854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation.
    Chen M; Liang D; Zuo A; Shao H; Kaplan HJ; Sun D
    PLoS One; 2015; 10(7):e0132348. PubMed ID: 26147733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
    Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
    J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBI3 is pivotal for the initiation of experimental autoimmune uveitis.
    Takeda A; Hasegawa E; Fukuhara T; Hirakawa S; Yamada H; Yang Y; Yoshimura T; Hisatomi T; Oshima Y; Yoshida H; Sonoda KH; Ishibashi T
    Exp Eye Res; 2014 Aug; 125():107-13. PubMed ID: 24929202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.
    Yu CR; Lee YS; Mahdi RM; Surendran N; Egwuagu CE
    PLoS One; 2012; 7(1):e29742. PubMed ID: 22238646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12p40 Homodimer Ameliorates Experimental Autoimmune Arthritis.
    Lee SY; Jung YO; Kim DJ; Kang CM; Moon YM; Heo YJ; Oh HJ; Park SJ; Yang SH; Kwok SK; Ju JH; Park SH; Sung YC; Kim HY; Cho ML
    J Immunol; 2015 Oct; 195(7):3001-10. PubMed ID: 26324771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis.
    Ke Y; Sun D; Jiang G; Kaplan HJ; Shao H
    J Immunol; 2011 Sep; 187(5):2130-9. PubMed ID: 21795593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
    Yu CR; Kim SH; Mahdi RM; Egwuagu CE
    J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.
    Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D
    J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.